Hinge Health, Inc. HNGE
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 100.92% | -2,040.15% | -5,199.88% | -- | -- |
| Total Depreciation and Amortization | -9.29% | -6.07% | -9.23% | -- | -- |
| Total Amortization of Deferred Charges | 63.72% | 56.13% | 48.20% | -- | -- |
| Total Other Non-Cash Items | -67.83% | 7,172.16% | 6,418.20% | -- | -- |
| Change in Net Operating Assets | 233.98% | -94.44% | -114.92% | -- | -- |
| Cash from Operations | 216.46% | 142.07% | 249.87% | -- | -- |
| Capital Expenditure | 7.50% | 22.92% | 31.86% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 100.00% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -44.86% | -205.21% | -663.56% | -- | -- |
| Cash from Investing | -10.38% | -130.41% | -721.25% | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -93.28% | 40,874.85% | 43,376.07% | -- | -- |
| Repurchase of Common Stock | 12.11% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.50% | -5,072.55% | -1,870.66% | -- | -- |
| Cash from Financing | -201.24% | -14,610.04% | -6,733.24% | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 26,654.40% | -247.69% | -242.51% | -- | -- |